Global Pulmonary Drug DeliveryDevices/Systems Market is
expected to reach USD 55.1 billion by 2025, according to a new report by
Grand View Research, Inc., Increasing prevalence of chronic respiratory
diseases is expected to boost the adoption of Pulmonary Drug Delivery Systems
(PDDS). As per WHO, 235 million people suffer from asthma globally. Majority of
the asthma related deaths occur in middle- to low-income countries due to lack
of treatment options. This shows the potential demand for pulmonary drug
delivery systems in the coming years.
Technological advancements in the field of
drug delivery are expected to positively impact the pulmonary drug delivery
devices market. These advancements include incorporation of agglomerated
vesicle technology, MDI electronic dose counter, particle engineering, and
supercritical fluid technology. Rising demand for new products, changing
lifestyle, ease of use, and better facilities are factors expected to provide
lucrative opportunities.
Furthermore, rise in number of public and
private organizations is another major factor propelling the growth of
pulmonary drug delivery devices market. For instance, organizations such as the
Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI)
are engaged in providing information in clinical and basic research on allergy,
asthma, and clinical immunology. Such initiatives are in turn expected to
increase the market demand for respiratory drug delivery devices in developing
regions, thereby boosting overall market growth.
Full Research Report on Global Pulmonary
Drug Delivery Devices/Systems Analysis:
http://www.grandviewresearch.com/industry-analysis/pulmonary-drug-delivery-systems-market
http://www.grandviewresearch.com/industry-analysis/pulmonary-drug-delivery-systems-market
Further Key Findings From the Study
Suggest:
- Metered dose inhaler segment held the dominant share owing to
its low cost and high adoption rate due to early introduction in the
market
- Chronic Obstructive Pulmonary Diseases (COPD) segment is
anticipated to grow at a lucrative CAGR due to the presence of favorable reimbursement
policies for treatment of COPD
- High number of patients affected by asthma in developing and
developed regions is likely to support the development of asthma
applications for respiratory drug delivery devices
- E-commerce segment is expected to witness lucrative growth.
Development of this segment is supported by its associated benefits such
as convenience, discounts, and flexibility
- Home care segment is expected to exhibit exponential growth due
to the introduction of technologically advanced, portable, and small-sized
devices that can be used at home
- Asia Pacific region is anticipated to grow at a lucrative CAGR.
High prevalence of COPD, indicating a substantial socioeconomic burden in
this region drives the growth in Asia Pacific
- The market is progressing due to the rising demand for better
treatment options, efficient drug delivery, and rapid treatment of local
respiratory disorders
View
more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/medical-devices
Grand
View Research has segmented the Global Pulmonary Drug Delivery Systems Market
on the basis of product, application, distribution channel, end use, and
region:
Pulmonary Drug Delivery Systems Product
Outlook (Revenue, USD Million, 2014 - 2025)
- Metered Dose Inhalers (MDIs)
- Dry Powder Inhalers (DPIs)
- Nebulizers
·
Mesh
§ Vibrating
§ Static
·
Pneumatic
§ Vented
§ Breath Actuated
·
Ultrasonic
·
Accessories
Pulmonary Drug Delivery Systems Application
Outlook (Revenue, USD Million, 2014 - 2025)
- Asthma
- Cystic Fibrosis
- COPD
- Allergic Rhinitis
- Others
Pulmonary Drug Delivery Systems
Distribution Channel Outlook (Revenue, USD Million, 2014 - 2025)
- Retail Pharmacies
- Hospital Pharmacies
- E-Commerce
Pulmonary Drug Delivery Systems End Use
Outlook (Revenue, USD Million, 2014 - 2025)
- Hospitals & Clinic
- Homecare
Pulmonary Drug Delivery Systems Regional
Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia Pacific
- Japan
- China
- India
- Latin America
- Brazil
- Mexico
- MEA
- South Africa
View Press Release Of This Report by
Grand View Research: http://www.grandviewresearch.com/press-release/global-pulmonary-drug-delivery-devices-systems-market
About Grand View
Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more Information visit: www.grandviewresearch.com
No comments:
Post a Comment